Phoenix Rises as the Nation’s Premier Bioscience Powerhouse
Under the visionary leadership of Mayor Kate Gallego, Phoenix has transformed into one of the nation’s fastest-rising bioscience hubs. By seamlessly pairing long-term infrastructure investment with forward-thinking economic development strategies, talent cultivation, and dynamic public-private partnerships, Gallego has redefined the city’s economic landscape. In her vision, bioscience is far more than a healthcare initiative—it is a foundational pillar of Phoenix’s future economy, standing proudly alongside semiconductors, engineering, and advanced manufacturing.
Kate Gallego
Mayor of the City of Phoenix
A defining milestone in this transformation came in 2026 when Mayor Gallego and the Phoenix City Council approved a historic $50 million investment in ASU Health at the Phoenix Bioscience Core (PBC). Marking the largest direct bioscience investment in the city’s history, the package cleverly combined voter-approved bond funding with an additional commitment from the newly renamed Sports Facilities, Biosciences, and Tourism Fund. Expanding the traditional sports and tourism fund to explicitly encompass bioscience signaled a monumental policy shift: Phoenix now officially recognizes life sciences as a primary economic engine capable of generating high-paying jobs, cutting-edge innovation, global investment, and high-value economic activity.
Addressing business and community leaders during her annual State of the City address downtown, Mayor Gallego highlighted the extraordinary growth and impact of Arizona’s bioscience sector. She praised the continued expansion of the Phoenix Bioscience Core with ASU Health—which includes a new medical school—alongside the $1.9 billion planned transformation at Mayo Clinic and the celebration of the first graduating class from the Midtown campus of the Creighton University School of Medicine.
Phoenix is an international leader in precision medicine and a pioneer in translational research, supported by four premier biotech hubs spanning 30 to 200 acres. As the fifth largest and one of the fastest-growing cities in the U.S., it ranks among the top 20 life science markets and is the No. 1 large city for startups and advanced manufacturing growth. Phoenix fosters a collaborative, bio innovation-driven community committed to driving translational discovery to deliver a healthier future for all. Its rapid life science expansion is powered by strong partnerships with leading research institutes, top-ranked hospitals and universities, federal research institutions, and global biopharma companies. Phoenix is where ideas are nurtured, innovation is celebrated and new explorers are welcomed.
“Investments in the biosciences are bearing fruit . . . and it’s no time to rest,” Gallego declared during her 2026 State of the City address. “Phoenix is committed to advancing medicine and improving healthcare outcomes for all Arizonans . . . whether you live in Phoenix, Flagstaff, or the Navajo Nation.”
With more than 8.5 million square feet of bioscience and healthcare facilities currently under development or in the pipeline, the momentum is undeniable. The decision to rebrand the district as a “bioscience core”—roughly bounded from Van Buren to Polk and 4th Street to 7th Street—reflects the evolution of the industry. While early 2000s efforts focused strictly on biomedicine and medical schools, today’s landscape encompasses implantable and wearable technologies, soft-edge urban integration, and collaborative academic hubs featuring the University of Arizona, Arizona State University and Northern Arizona University.
Today, Phoenix leads the country in life science job growth and university spinoffs. Local startups are driving breakthroughs ranging from cutting-edge mRNA technology to early-stage cancer diagnostics. As international companies flock to Phoenix seeking a strategic foothold in the North American market, the city’s message is clear: Phoenix is no longer just building a medical hub—it is building the future of global medicine.